 Preexisting ascites and pericardial effusions should be monitored closely for signs of worsening.The dosage in patients without severe renal impairment is 50 µg/kg subcutaneously once a day either abdominal, in thigh, or hip.Most patients will be able to self-administer the drug after appropriate training.